期刊文献+

我院2002—2005年儿科药物利用分析

The Situation of Drug Use in Pediatrics of Fuzhou General Hospital during 2002—2005
下载PDF
导出
摘要 目的了解南京军区福州总医院儿科药物利用的现状和趋势,分析存在的问题。方法随机抽取该院2002年1月~2005年4月间儿科出院病历800份(每年200份),对用药种类、金额、用药频度和合理用药情况进行统计分析。结果儿科抗感染药物所占比例较大(每年均在50%左右),但有逐年减少的趋势;抗生素使用率偏高(占96.13%)。结论抗生素使用范围有扩大倾向,儿科处方存在重复给药、药物配伍不当、使用该年龄组禁用药、抗生素不合理联用等现象。 Objective To study the condition of drug use in pediatrics in our hospital. To analyse the problems and to provide the theoretical foundation for the rational use of drugs in pediatrics. Methods To randomly select 800 medical records of children in our hospital in 2002- 2005 and to statistically analyze the drugs. Results The anti- infectives took an important part in the pediatrics- used drugs. Antiinfectives occupied half proportion of cost every year. The cost of anti- infectives was decreased in pediatrics, The utilization rate of antibiotic drugs was 96. 13%. Conclusion The application range of antibiotics has a tendency to broaden. There is some unreasonable conditions in using drugs, for example, repeatedly taking medicine, incompatibility of drugs in a prescription, using the drugs forbidden to children, unreasonable combined use of antibiotics and so on.
出处 《中国药业》 CAS 2006年第12期37-39,共3页 China Pharmaceuticals
关键词 儿科 药物利用 合理用药 pediatrics drug application rational use of drug
  • 相关文献

参考文献3

二级参考文献26

  • 1杨继章,杨树民.抗生素后效应与临床用药决策[J].上海医药,2005,26(1):18-20. 被引量:18
  • 2杨继章,陈大华,杨树民.喹诺酮类药物在儿科领域应用的前景分析[J].上海医药,2005,26(3):105-107. 被引量:7
  • 3杨继章,陈大华,杨树民.喹诺酮类药物在老年人中的合理应用[J].上海医药,2005,26(5):203-205. 被引量:7
  • 4小林宏行 和田光一 等.格雷沙星和氧氟沙星对肺炎治疗的双盲比较试验研究[J].日本化学疗法学会杂志,1997,45(6):442-442.
  • 5宋兆力 王力谱 黄云峻.氟喹诺酮类新药--格雷沙星[J].中国新药杂志,1998,12(7):161-161.
  • 6Wexler HM, Molitoris E, Finegoold SM. In vitro activity of grepafloxacin( OPC - 17116) against anaerobic bacteria. Diagn Microbiol Infect Dis, 1994, 19(2) :129.
  • 7Spangler SK, Jacobs MK, Appelbaum PC. Activity of CP99219compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin piperacillin and piperacillin -tazobactam against 489 anaerobes. Antimicrob Agents Chemother, 1994, 38(12) :2741.
  • 8Wesler HM, Molitoris E, Reeves D, et al. In vitro activity of clindafloxacin ( CI - 960) and PD131628 - 2 against anaerobic bacteria. J Antinicrob, 1994, 34(8) :579.
  • 9Davies TA, Kelly LM, Pankuch GA, et al. Antipneumococcal activities of gemifloxacin compared to those of nine other agents.Antimicrob Agents Chemother , 2000, 44(2) :304.
  • 10Dubois J, St - Pierre C. Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp. J Antimicrob Chemother. 2000, 45 (Suppl 1 ) :41.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部